Get the content you want anytime you want.
The Best Infectious Disease News Delivered Weekly

The Contagion® HIV / AIDS specialty page provides HIV/AIDS-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.

HIV / AIDS NEWS - Page 9

Dapivirine Ring Shown to Reduce HIV-Risk in Women by 54%
Interim results of the HOPE study reveal that the vaginal ring reduced women’s risk of acquiring HIV by more than 50%. Women in this study are also using the ring more than in previous studies.
Out-Of-Pocket Costs Hinder PrEP Use Among Young MSM in the Private Health Care System
One study takes a look at how out-of-pocket costs impede the use of pre-exposure prophylaxis in young men who have sex with men.
South Still Disproportionately Affected by HIV Despite Decline in Diagnoses
Dr. Meg Watson from the CDC reports updated information regarding the current rates and trends of HIV diagnoses in the South at 2018 CROI.
Bending & Ending the HIV Epidemic: Are We on Track to Meet 90-90-90 Goals?
At CROI 2018, Dr. Helen Weiss highlighted where we are in terms of meeting these goals, where the challenges are, and strategies to help prevent new infections.
Assessing Interest in New Antiretroviral Therapies May Help Inform Uptake & Adherence
In an oral abstract session at CROI 2018, Dr. Nathan Thielman stresses that understanding the interest of HIV-positive treatment-experienced individuals in new antiretroviral therapies may help inform their development and uptake.
Vaginal Microbiome May Influence Effectiveness of Pre-Exposure Prophylaxis
Better understanding of the vaginal microbiome may provide new insights into HIV acquisition.
WHO Launches New Guidance On Cryptococcal Meningitis
At CROI 2018, the World Health Organization released updated guidelines for cryptococcal disease in HIV-infected adults.
Dolutegravir Effective and Well-Tolerated in HIV/TB Co-Infected Adults
Study results revealed that dolutegravir appears to be effective and well-tolerated in HIV/tuberculosis (TB) co-infected adults also receiving rifampin-based TB therapy.
Big advances in treatment can